SEPRAGEL SINUS * 7089-0812

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2006-03-06 for SEPRAGEL SINUS * 7089-0812 manufactured by Genzyme Biosurgery.

Event Text Entries

[468527] Pt developed tingling and numbness of the right face four days after using sepragel sinus during tympanoplasty. Sepragel sinus was used to fill the middle ear to hold the graft. He later developed total paralysis of the right face 6 days following tympanoplasty. He had a magnetic resonance imaging -mri- 1 week after the right facial paralysis and an enhancing soft tissue fills the right tympanic cavity and portions of the mastoid which i think represents the sepragel sinus used during the procedure. This abuts and obsures the tympanic and mastoid segments of the facial nerve. He was given decadron 10 mg i. V. Followed by prednisone for 3 weeks and famvir for 10 days. He recovered uneventfully 1 week later.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW1038220
MDR Report Key692755
Date Received2006-03-06
Date of Report2006-03-06
Date of Event2005-12-03
Date Added to Maude2006-03-30
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA0
Report to FDA0
Event Location3
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Details

Brand NameSEPRAGEL SINUS
Generic NameHYALURONIC ACID - GEL FORM-
Product CodeKHJ
Date Received2006-03-06
Model Number*
Catalog Number7089-0812
Lot Number805031
ID Number*
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Implant FlagY
Date Removed*
Device Sequence No1
Device Event Key681907
ManufacturerGENZYME BIOSURGERY
Manufacturer Address* CAMBRIDGE MA * US


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2006-03-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.